Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Marburg Vaccine in Uganda
Clinical Trial Preparation WASHINGTON, Oct. 19, 2023 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate
Clinical Trial Preparation WASHINGTON, Oct. 19, 2023 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate
Wood Mackenzie report says new metallic hubs will emerge as steel industry accelerates carbon abatement efforts LONDON and HOUSTON and SINGAPORE, Oct. 19, 2023 (GLOBE
Wood Mackenzie report says new metallic hubs will emerge as steel industry accelerates carbon abatement efforts LONDON and HOUSTON and SINGAPORE, Oct. 19, 2023 (GLOBE
RIYAD, Arabie Saoudite, 18 oct. 2023 (GLOBE NEWSWIRE) — La Semaine 2023 du Climat de la région MOAN organisée à Riyad a mis en évidence
RIAD, Arábia Saudita, Oct. 18, 2023 (GLOBE NEWSWIRE) — A Middle East and North Africa Climate Week (MENACW) 2023, sediada em Riad, enfatizou o papel
Superbo x Microsoft DUBAI, United Arab Emirates, Oct. 18, 2023 (GLOBE NEWSWIRE) — Superbo, a pioneering provider of advanced AI solutions, is thrilled to announce